"Receptors, Transferrin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Membrane glycoproteins found in high concentrations on iron-utilizing cells. They specifically bind iron-bearing transferrin, are endocytosed with its ligand and then returned to the cell surface where transferrin without its iron is released.
| Descriptor ID |
D011990
|
| MeSH Number(s) |
D12.776.157.905.500 D12.776.543.750.800
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Transferrin".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Transferrin".
This graph shows the total number of publications written about "Receptors, Transferrin" by people in this website by year, and whether "Receptors, Transferrin" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 2 | 4 | 6 |
| 1997 | 2 | 2 | 4 |
| 1998 | 4 | 3 | 7 |
| 1999 | 1 | 3 | 4 |
| 2000 | 0 | 4 | 4 |
| 2001 | 0 | 3 | 3 |
| 2002 | 2 | 2 | 4 |
| 2003 | 2 | 9 | 11 |
| 2004 | 3 | 5 | 8 |
| 2005 | 2 | 1 | 3 |
| 2006 | 4 | 3 | 7 |
| 2007 | 4 | 2 | 6 |
| 2008 | 1 | 7 | 8 |
| 2009 | 2 | 7 | 9 |
| 2010 | 3 | 9 | 12 |
| 2011 | 4 | 4 | 8 |
| 2012 | 3 | 2 | 5 |
| 2013 | 0 | 5 | 5 |
| 2014 | 2 | 3 | 5 |
| 2015 | 7 | 2 | 9 |
| 2016 | 1 | 4 | 5 |
| 2017 | 0 | 4 | 4 |
| 2018 | 1 | 1 | 2 |
| 2019 | 3 | 1 | 4 |
| 2020 | 3 | 5 | 8 |
| 2021 | 3 | 2 | 5 |
| 2022 | 1 | 4 | 5 |
| 2023 | 0 | 1 | 1 |
| 2024 | 2 | 2 | 4 |
| 2025 | 1 | 0 | 1 |
Below are the most recent publications written about "Receptors, Transferrin" by people in Profiles.
-
Assessment of serum soluble transferrin receptor in adult Egyptian aplastic anemia patients. Egypt J Immunol. 2025 Jan; 32(1):42-49.
-
Designed endocytosis-inducing proteins degrade targets and amplify signals. Nature. 2025 Feb; 638(8051):796-804.
-
Multiple Infections, Nutrient Deficiencies, and Inflammation as Determinants of Anemia and Iron Status during Pregnancy: The MINDI Cohort. Nutrients. 2024 Jun 02; 16(11).
-
Iron controls the development of airway hyperreactivity by regulating ILC2 metabolism and effector function. Sci Transl Med. 2024 May 08; 16(746):eadk4728.
-
Bone marrow Tfr2 deletion improves the therapeutic efficacy of the activin-receptor ligand trap RAP-536 in β-thalassemic mice. Am J Hematol. 2024 07; 99(7):1313-1325.
-
α-L-iduronidase fused with humanized anti-human transferrin receptor antibody (lepunafusp alfa) for mucopolysaccharidosis type I: A phase 1/2 trial. Mol Ther. 2024 Mar 06; 32(3):609-618.
-
Placental ferroportin protein abundance is associated with neonatal erythropoietic activity and iron status in newborns at high risk for iron deficiency and anemia. Am J Clin Nutr. 2024 01; 119(1):76-86.
-
A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease. Kidney Int. 2023 07; 104(1):61-73.
-
Iron Status and Homeostasis Across 2 Competitive Seasons in NCAA Division I Collegiate Cross-Country Runners Residing at Low Altitude. Int J Sports Physiol Perform. 2022 Dec 01; 17(12):1716-1724.
-
LC3-dependent EV loading and secretion (LDELS) promotes TFRC (transferrin receptor) secretion via extracellular vesicles. Autophagy. 2023 05; 19(5):1551-1561.